Association Between Component-Resolved Diagnosis of House Dust Mite Allergy and Efficacy and Safety of Specific Immunotherapy

J Investig Allergol Clin Immunol. 2019 Apr;29(2):164-167. doi: 10.18176/jiaci.0359.

Authors

E Arroabarren¹, S Echechipía¹, A Galbete², M T Lizaso¹, J M Olaguibel^{1

3}, A I Tabar^{1

4

5}

Affiliations

¹ Servicio de Alergologia, Complejo Hospitalario de Navarra, Pamplona, Spain.
² Navarrabiomed- Centro Hospitalario de Navarra-UPNA, Pamplona, Spain.
³ CIBER Respiratorio.
⁴ Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
⁵ RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL).

PMID: 31017124
DOI: 10.18176/jiaci.0359

No abstract available

Keywords: Allergen immunotherapy; Component resolved diagnosis (CRD); Efficacy; House dust mite; Major allergens.

Publication types

Clinical Trial, Phase IV
Randomized Controlled Trial

MeSH terms

Adolescent
Adult
Allergens / adverse effects*
Antigens, Dermatophagoides / adverse effects*
Child
Child, Preschool
Humans
Hypersensitivity / diagnosis*
Hypersensitivity / therapy*
Immunoglobulin E / blood
Immunotherapy*
Middle Aged
Treatment Outcome
Young Adult

Substances

Allergens
Antigens, Dermatophagoides
Immunoglobulin E